Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

427 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Randomized trial to evaluate the addition of tamoxifen to cyclophosphamide, 5-fluorouracil, prednisone adjuvant therapy in premenopausal women with node-positive breast cancer.
Ingle JN, Everson LK, Wieand HS, Cullinan SA, Wold LE, Hagen JB, Martin JK, Krook JE, Fitzgibbons RG, Foley JF, et al. Ingle JN, et al. Cancer. 1989 Apr 1;63(7):1257-64. doi: 10.1002/1097-0142(19890401)63:7<1257::aid-cncr2820630705>3.0.co;2-x. Cancer. 1989. PMID: 2646004 Clinical Trial.
DNA content flow cytometry as a prognostic factor for node-positive breast cancer. The role of multiparameter ploidy analysis and specimen sonication.
Witzig TE, Gonchoroff NJ, Therneau T, Gilbertson DT, Wold LE, Grant C, Grande J, Katzmann JA, Ahmann DL, Ingle JN. Witzig TE, et al. Among authors: ingle jn. Cancer. 1991 Oct 15;68(8):1781-8. doi: 10.1002/1097-0142(19911015)68:8<1781::aid-cncr2820680822>3.0.co;2-0. Cancer. 1991. PMID: 1913523 Clinical Trial.
Combination hormonal therapy with tamoxifen plus fluoxymesterone versus tamoxifen alone in postmenopausal women with metastatic breast cancer. An updated analysis.
Ingle JN, Twito DI, Schaid DJ, Cullinan SA, Krook JE, Mailliard JA, Tschetter LK, Long HJ, Gerstner JG, Windschitl HE, et al. Ingle JN, et al. Cancer. 1991 Feb 15;67(4):886-91. doi: 10.1002/1097-0142(19910215)67:4<886::aid-cncr2820670405>3.0.co;2-o. Cancer. 1991. PMID: 1991261 Clinical Trial.
A double-blind trial of tamoxifen plus prednisolone versus tamoxifen plus placebo in postmenopausal women with metastatic breast cancer. A collaborative trial of the North Central Cancer Treatment Group and Mayo Clinic.
Ingle JN, Mailliard JA, Schaid DJ, Krook JE, Gesme DH Jr, Windschitl HE, Pfeifle DM, Etzell PS, Gerstner JG, Long HJ, et al. Ingle JN, et al. Cancer. 1991 Jul 1;68(1):34-9. doi: 10.1002/1097-0142(19910701)68:1<34::aid-cncr2820680107>3.0.co;2-q. Cancer. 1991. PMID: 2049750 Clinical Trial.
Randomized clinical trial of CFP versus CMFP in women with metastatic breast cancer.
Marschke RF Jr, Ingle JN, Schaid DJ, Krook JE, Mailliard JA, Cullinan SA, Pfeifle DM, Votava HJ, Ebbert LP, Windschitl HE. Marschke RF Jr, et al. Among authors: ingle jn. Cancer. 1989 May 15;63(10):1931-7. doi: 10.1002/1097-0142(19890515)63:10<1931::aid-cncr2820631011>3.0.co;2-f. Cancer. 1989. PMID: 2649221 Clinical Trial.
Randomized trial of observation versus adjuvant therapy with cyclophosphamide, fluorouracil, prednisone with or without tamoxifen following mastectomy in postmenopausal women with node-positive breast cancer.
Ingle JN, Everson LK, Wieand HS, Martin JK, Votava HJ, Wold LE, Krook JE, Cullinan SA, Paulsen JK, Twito DI, et al. Ingle JN, et al. J Clin Oncol. 1988 Sep;6(9):1388-96. doi: 10.1200/JCO.1988.6.9.1388. J Clin Oncol. 1988. PMID: 3047333 Clinical Trial.
427 results